Brooks Laboratories (BROOKS) | Stock Overview & Key Data
Brooks Laboratories Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹198.86 on January 6, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Peer Performance Comparison
No peer performance data available for this stock.
Brooks Laboratories Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Brooks Laboratories would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is BROOKS's 52-week high and low?
In the last 52 weeks, Brooks Laboratories reached a high of ₹198.86 (on January 7, 2025) and a low of ₹82.00 (on July 15, 2024).
What is the market cap and P/E ratio for BROOKS?
Curious about Brooks Laboratories's size and valuation? Its market capitalization stands at 4.07B. When it comes to valuation, the P/E ratio (trailing twelve months) is -37.18, and the forward P/E (looking ahead) is N/A.
Does BROOKS pay dividends? If so, what's the yield?
As for dividends, Brooks Laboratories isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Brooks Laboratories's main competitors or similar companies to consider before investing?
When looking at Brooks Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
No specific competitor data is currently available for comparison in this section.
What are the key financial health indicators for Brooks Laboratories Ltd.? (e.g., ROE, Debt/Equity)
To get a sense of Brooks Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
What is the recent revenue and earnings growth for BROOKS?
Looking at Brooks Laboratories's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
How much of BROOKS stock is held by insiders and institutions?
Wondering who owns Brooks Laboratories stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.